Health Care/Hospital

Kiwa Bio-Tech Third Quarter Revenues Increase 226% - Nine-Month Revenues $6.2 Million

BEIJING and CLAREMONT, Calif., Nov. 7 /Xinhua-PRNewswire/ -- Kiwa Bio-Tech Products Group Corporation (OTC Bulletin Board: KWBT) announced that revenues for the first nine months of 2007 were $6,214,712 an increase of 567% over $930,442 in the first nine months of 2006. Revenues for the ...

2007-11-08 06:16 548

JPMorgan's Principal Investment Management Group to Invest in Chindex International, Inc.

$50 Million Investment to Finance Growth in Chindex's Healthcare Network in China BETHESDA, Md., Nov. 7 /Xinhua-PRNewswire/ -- Chindex International, Inc. (Nasdaq: CHDX) a leading independent American provider of Western healthcare services and products in the People's Republic of China, toda...

2007-11-07 22:44 1006

Shire Announces Results of FOSRENOL(R) Study in Pre-Dialysis CKD Stage 3 & 4 Patients

PHILADELPHIA and BASINGSTOKE, England, Nov. 6 /Xinhua-PRNewswire/ -- Shire plc (LSE: SHP, Nasdaq: SHPGY, TSX: SHQ) today announced the results of a Phase II study indicating that FOSRENOL can effectively reduce serum phosphate levels in chronic kidney disease (CKD) patients not on dialys...

2007-11-06 23:04 685

Mindray Medical Announces Highlights for its 2007 Analyst & Investor Day

SHENZHEN, China, Nov. 6 /Xinhua-PRNewswire-FirstCall/ -- Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices in China with a rapidly growing international presence, today announced key highlights from its 2007 Analyst & Investor Day...

2007-11-06 21:30 890

Fenofibrate - First Lipid Modifying Agent Shown to Protect Diabetic Eye

SYDNEY, Australia, Nov. 6 /Xinhua-PRNewswire/ -- - First Lipid Modifying Agent Shown to Reduce Risk of Leading Causes of Blindness and Deteriorating Vision in Patients With Type 2 Diabetes - Reduces Need for Laser Treatment in Patients With and Without Known ...

2007-11-06 08:26 793

Sanofi Pasteur Presents Positive Results of Tetravalent Dengue Candidate Vaccine

PARIS, Nov. 6 /Xinhua-PRNewswire/ -- Sanofi Pasteur, the vaccines division of sanofi-aventis Group, announced today positive results in the development of a vaccine for the global prevention of dengue fever, one of the most widespread tropical diseases. The results are being presented today at t...

2007-11-06 16:00 740

Simcere Pharmaceutical Group Reports Third Quarter 2007 Results

Net Income Increased 73% Year-over-year or 89% Year-to-date NANJING, China, Nov. 5 /Xinhua-PRNewswire-FirstCall/ -- Simcere Pharmaceutical Group (NYSE: SCR), a leading manufacturer and supplier of branded generic pharmaceuticals and manufacturer of the patented anti-cancer biotech product...

2007-11-05 20:00 727

In Landmark Phase III Head-to-Head Study, Prasugrel Statistically Superior to Clopidogrel in Reducing Risk of Heart Attack

Investigational compound reduces risk of major cardiovascular events by 19 percent, significantly improves net clinical benefit despite increased bleeding TOKYO and INDIANAPOLIS, Nov. 5 /Xinhua-PRNewswire/ -- In the pivotal Phase III head-to-head TRITON TIMI-38 clinical trial, the investiga...

2007-11-05 13:05 553

Daiichi Sankyo, Lilly Announce New Prasugrel Head-to-Head Phase III Study Against Clopidogrel

Duke Clinical Research Institute to lead multinational study with investigational compound; will include 10,000 medically managed patients with acute coronary syndrome TOKYO and INDIANAPOLIS, Nov. 5 /Xinhua-PRNewswire/ -- A large Phase III clinical trial is anticipated to begin in the secon...

2007-11-05 13:00 481

New Non-Clinical Data Links DYNEPO(R) (Epoetin Delta) to Reduced Angiogenic Potential

BASINGSTOKE, England, Nov. 5 /Xinhua-PRNewswire/ -- New data presented today at the 40th annual American Society of Nephrology (ASN) meeting and scientific exposition in San Francisco, CA, USA, show that epoetin delta -- the only erythropoiesis-stimulating agent (ESA) produced in a human cell li...

2007-11-05 16:00 611

Pharmaxis to Expand Manufacturing Capacity

SYDNEY, Australia, Nov. 2 /Xinhua-PRNewswire-FirstCall/ -- Pharmaxis (ASX: PXS; Nasdaq: PXSL) today announced moves to expand its manufacturing capacity with the signing of an agreement for the construction of a new state of the art facility at Frenchs Forest, Sydney. Following complet...

2007-11-02 21:00 498

Mindray Announces Appointment of Dr. Jixun Lin as Independent Director

SHENZHEN, China, Nov. 1 /Xinhua-PRNewswire-FirstCall/ -- Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices in China with a rapidly growing international presence, today announced the appointment of Dr. Jixun Lin as independent dir...

2007-11-02 05:10 913

Mindray Medical International Announces Third Quarter 2007 Results

Company Achieves Record Revenue Growth of 58.9% Year-over-Year SHENZHEN, China, Nov. 1 /Xinhua-PRNewswire-FirstCall/ -- Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices in China with a rapidly growing international presence, t...

2007-11-02 05:00 675

Skystar Bio-Pharmaceutical Receives Award for Avian Coccidiosis Vaccine Project

XI’AN, China, Nov. 1 /Xinhua-PRNewswire-FirstCall/ -- Skystar Bio-Pharmaceutical Co., Ltd. (OTC Bulletin Board: SKBI) ("Skystar", “Company”), a leading bio-pharmaceutical company in the People’s Republic of China ("PRC"), today announced that the Company was awarded the National High Technol...

2007-11-01 20:30 1225

Breaking News About Treatment of World’s Leading Cause of Adult Blindness to be Published Next Week

BRUSSELS, Belgium, Nov. 1 /Xinhua-PRNewswire/ -- First study to investigate the protective effect of a lipid-lowering agent on diabetic eye disease to be published on-line in Lancet, Tuesday, 6th November 2007 Diabetic eye disease (called diabetic retinopathy) is the leading cause of vi...

2007-11-01 08:40 853

2007 Luminous Award Winners Highlight Ovarian Cancer Treatment and the Importance of Early Detection

German and British reporters named winners of annual Luminous Award INDIANAPOLIS, Oct. 31 /Xinhua-PRNewswire/ -- One woman's courageous battle to find the best treatment to fight her ovarian cancer is the subject of the winning entry in the 2007 Luminous Award. Launched by Eli Lilly and Co...

2007-10-31 20:00 692

Quintiles Acquires Central American Research Organization

Bio-Trials to Complement Existing Quintiles Latin American Organization RESEARCH TRIANGLE PARK, N.C., Oct. 31 /Xinhua-PRNewswire/ -- Quintiles Transnational Corp. today announced that its Latin American subsidiary has purchased Bio-Trials, a leading Central American Clinical Research ...

2007-10-31 06:57 837

Mindray to Participate in the UBS 2007 China Life Sciences Conference

SHENZHEN, China, Oct. 30 /Xinhua-PRNewswire-FirstCall/ -- Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices in China with a rapidly growing international presence, today announced that Mr. Cheng Minghe, executive vice president of...

2007-10-30 20:00 834

China-Biotics, Inc. to Supply Probiotics to Relax Xinqiao Food Co.

SHANGHAI, China, Oct. 30 /Xinhua-PRNewswire-FirstCall/ -- China-Biotics, Inc. (OTC Bulletin Board: CHBT) ("China-Biotics", "the Company"), a leading Chinese firm specializing in the manufacture, research, development, marketing and distribution of probiotics products, today announced it has ...

2007-10-30 20:00 1310

3SBio Inc. To Present At The CIBC World Markets 18th Annual Healthcare Conference

SHENYANG, China, Oct. 29 /Xinhua-PRNewswire/ -- 3SBio Inc. (Nasdaq: SSRX), a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, announces today that David Chen, VP of Business Development, will present at the CIBC...

2007-10-30 05:14 787
1 ... 866867868869870871872 ... 890